EGFR Mutated, Stage IIIB/IIIC/IV or Recurrent, NSCLC (DBCOND0167811)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT06525246	ONO-7475-03: ONO-7475 Phase I Study An Open-label, Uncontrolled Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer	Osimertinib Tamnorzatinib	treatment	1	active_not_recruiting